Modelled DT Structure
Method: homology modeling
Template PDB: 6M97_A
Identity: 37.27%
Minimized Score: -186.099 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0280 | ||||
| Gene Name | SLC31A2 | ||||
| Protein Name | Probable low affinity copper uptake protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 6M97_A Identity: 37.27% Minimized Score: -186.099 kcal/mol Detail: Structure Info |
||||
| Synonyms | Copper transporter 2; hCTR2; COPT2; CTR2; SLC31A2; Solute carrier family 31 member 2 | ||||
| DT Family | Copper Transporter (CTR) Family ; | ||||
| Tissue Specificity | Ubiquitous. | ||||
| Function | This transporter involved in low-affinity copper uptake. | ||||
| Endogenous Substrate(s) | Cu+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Cisplatin
|
Approved | Drug Info | Testicular cancer | 2C80 | [1] |
| References | |||||
| 1 | Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo. Mol Pharmacol. 2011 Jan;79(1):157-66. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.